Clinical Trials
106 trialsCHRU-WCMC
University Hospital, Lille
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Lanzhou University Second Hospital
MRG003
Sun Yat-sen University
CISTO
University of Washington
TVNIM-AFU
Association Francaise d'Urologie
DutaBCa-1
CHU de Quebec-Universite Laval
MIDAS-Prostate
University Health Network, Toronto
Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions
Chang Gung Memorial Hospital
CRUCIAL-R
S. Andrea Hospital
SWENOTECA-ABC
St. Olavs Hospital
KP-CARAIBES
Centre Hospitalier Universitaire de la Guadeloupe
COBRA-NMIBC
Aarhus University Hospital
GEM-IR-NMIBC
Shanghai University of Traditional Chinese Medicine
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial
National Taiwan University Hospital
FocaSaBra
The Greater Poland Cancer Centre
CRYO-BO-2021
IRCCS Azienda Ospedaliero-Universitaria di Bologna
PREPARE
AIO-Studien-gGmbH
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Children's National Research Institute
Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
Dana-Farber Cancer Institute
Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma
Universitaire Ziekenhuizen KU Leuven
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
ProCaB
Universitaire Ziekenhuizen KU Leuven
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Wroclaw Medical University
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy
University of Vermont
GTN
Queen's University
HETERERO
Charite University, Berlin, Germany
Kidney Cancer Observational Protocol
IRCCS San Raffaele
DMIA
Vitadx
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
MINERVA
Medical University of Vienna
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation
Ankara Training and Research Hospital
FIPC
Urological Research Network, LLC
MRFLA
Urological Research Network, LLC
JAVA-P
University Hospitals Bristol and Weston NHS Foundation Trust
An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer
Shanghai Pudong Hospital
STARR
Azienda Ospedaliero-Universitaria Careggi
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
Istanbul Medeniyet University
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial
Mansoura University
RB-PSMA
University Hospital, Brest
Robotic Radical Cystectomy Outcomes
University of Florence
PF-03446962 in Relapsed or Refractory Urothelial Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Roswell Park Cancer Institute
The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence
Mansoura University
Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers
Mansoura University
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
Barbara Ann Karmanos Cancer Institute
The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.
Mansoura University